Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04431128
Other study ID # Clalit HS
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 1, 2003
Est. completion date June 6, 2020

Study information

Verified date June 2020
Source Hadassah Medical Organization
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

500 children aged 0-5 years followed since birth by Principal Investigator (PI)since January1, 2003 till December 31, 2018 and diagnosed with adenoid hypertrophy (AH) (study group) and 500 children aged 0-5 years followed by principal investigator during the same years and diagnosed as urinary tract infection (UTI), gastroenteritis (GE), diarrhea, vomiting but without AH (control group) were compared. Morbidity and treatment will be compared and correlated with gastro-esophageal reflux (GER), allergy and infant feeding position during the first few years of life in the two groups.


Description:

The 2 groups are children aged 0-5 years and treated by PI and followed since birth during years 2003-2018. Study group consists of children diagnosed at least 2 times as AH and control group as similar children with UTI, GE, vomiting or diarrhea. Respiratory problems (pneumonia, bronchopneumonia, bronchitis), ear problems (otitis media OM, serous OM), antibiotic treatment, use of bronchodilators, inhaled corticosteroid (ICS), chest X-rays, anomalous laboratory results, emergency room visits and hospitalization rates will be compared in the two groups, together with details concerning feeding position during the first years of life. Correlation between morbidity, degree of nasopharyngeal obstruction, allergy, GER and supine feeding position, will be evaluated.


Recruitment information / eligibility

Status Completed
Enrollment 500
Est. completion date June 6, 2020
Est. primary completion date December 31, 2018
Accepts healthy volunteers No
Gender All
Age group 1 Month to 5 Years
Eligibility Inclusion Criteria: Study group: Young children with diagnosis of adenoid hypertrophy followed by PI Control group: young children with diagnosis of UTI, GE, vomiting or diarrhea followed by PI

Exclusion Criteria: Children with cystic fibrosis, primary dyskinesia, immune deficiency, congenital anatomical malformations of nasal or airway passages.

Children older than 6 months of age when starting to be followed by PI.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
infant feeding position
correlation with allergy, GER or feeding position

Locations

Country Name City State
Israel Hadassah Medical Organization, Jerusalem, Israel Jerusalem

Sponsors (2)

Lead Sponsor Collaborator
Hadassah Medical Organization Clalit Health Services

Country where clinical trial is conducted

Israel, 

References & Publications (3)

Avital A, Donchin M, Springer C, Cohen S, Danino E. Feeding young infants with their head in upright position reduces respiratory and ear morbidity. Sci Rep. 2018 Apr 26;8(1):6588. doi: 10.1038/s41598-018-24636-0. — View Citation

Konno A, Hoshino T, Togawa K. Influence of upper airway obstruction by enlarged tonsils and adenoids upon recurrent infection of the lower airway in childhood. Laryngoscope. 1980 Oct;90(10 Pt 1):1709-16. — View Citation

Tully SB, Bar-Haim Y, Bradley RL. Abnormal tympanography after supine bottle feeding. J Pediatr. 1995 Jun;126(6):S105-11. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Respiratory complications Number of participants with Pneumonia, bronchitis 3 years
Primary Ear complications Number of participants with otitis media, serous otitis media 3 years
Secondary Correlations between morbidity, degree of adenoid hypertrophy and feeding position Correlation between respiratory morbidity, ear morbidity, laboratory and chest & nasopharynx X-rays with feeding position in first year of life
Correlation between respiratory and ENT morbidity with degree of adenoid obstruction, allergy, GER and infant feeding position during the first 2 years of life.
5 years
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT02205580 - Continuous Intravenous Sufentanil Infusion for Postoperative Pain Management Following Tonsillectomy or Adeno-tonsillectomy in Children Phase 4
Not yet recruiting NCT05402267 - The Effects of Exosomes in Otitis Media With Effusion
Withdrawn NCT04302337 - Conventional Curettage Adenoidectomy vs Curettage Adenoidectomy With Transoral Endoscopic Residue Ablation in Children N/A
Completed NCT03677453 - Interactive Perioperative Teaching Platform (IPTP) N/A
Recruiting NCT04646525 - The Relationship Between Covid-19 Infection in Pediatric Patients and Secondary Lymphoid Organs
Completed NCT04152746 - Periostin Levels in Children With Adenoid Hypertrophy
Not yet recruiting NCT03243565 - Effect of OM-85 on Respiratory Tract Infections and Adenoid Tissue in Children With Adenoid Hypertrophy Phase 4
Completed NCT03902314 - Lidocaine Infusion for Pain Relief in Children Scheduled for Tonsillectomy and Adenoidectomy Phase 4
Not yet recruiting NCT05291312 - EACA VS CCA in Postoperative Evaluation of Middle Ear Pressure N/A
Enrolling by invitation NCT06266429 - Metabolomic Profiling of Racial Disparity
Completed NCT03714919 - A Pilot Study: a Non-opioid Technique for Postoperative Adenoidectomy Pain Relief in Pediatric Patients Phase 2
Not yet recruiting NCT03890692 - Methods of Assessment of Adenoid Size N/A